AI ethics statements issued by major radiology groups

AI ethics statements issued by major radiology groups

by Thomas Dworetzky, Contributing Reporter | October 02, 2019
Artificial Intelligence Business Affairs

There is also the international nature of AI. Guerbet and IBM Watson Health inked an agreement in late September to co-develop an AI solution to help clinicians diagnose and monitor patients with prostate cancer. In 2018, the two companies reached a deal to use AI for liver cancer.

Because of this international aspect of AI work, including rapid technology development and cross-border deployment of AI software, “an ethical framework for AI in radiology was much needed," stressed Dr. An Tang, chair of CAR's AI Working Group and co-author of the joint statement.

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.


That said, there is no turning back from the use of big data and AI, as it continues to make inroads into many areas of diagnosis and treatment. “Applications of AI to patient care in imaging have great potential, both for good as well as unintended consequences,” said Dr. Marc D. Kohli, associate professor of radiology and biomedical imaging, medical director of imaging informatics for UCSF Health.

In order to allay such unintended issues, the authors stressed that in the end, human radiologists will need to remain involved, informed and vigilant as new tools come online.

“The application of AI tools in radiological practice lies in the hand of the radiologists, which also means that they have to be well-informed not only about the advantages they can offer to improve their services to patients, but also about the potential risks and pitfalls that might occur when implementing them,” said Dr. Erik R. Ranschaert, president of EuSoMII.

Cynthia McCollough, PhD, president of the AAPM stressed that the key lay in ensuring that variability and bias are minimized as machines and big data become more deeply ingrained into the fabric of healthcare delivery.

“In order for AI technology to positively impact human health, it is crucial that robust and reproducible data, methods, guidelines, and tools are developed and made available, she stressed, advising that “as quantitative and interdisciplinary scientists, medical physicists are playing an essential role in the development of these essential resources.”

Back to HCB News

You Must Be Logged In To Post A Comment